A detailed history of Gould Capital, LLC transactions in Boston Scientific Corp stock. As of the latest transaction made, Gould Capital, LLC holds 123 shares of BSX stock, worth $10,285. This represents 0.01% of its overall portfolio holdings.

Number of Shares
123
Holding current value
$10,285
% of portfolio
0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$67.33 - $77.71 $8,281 - $9,558
123 New
123 $9,000
Q2 2023

Aug 14, 2023

SELL
$49.72 - $54.64 $35,798 - $39,340
-720 Reduced 3.68%
18,862 $1.02 Million
Q1 2023

May 15, 2023

SELL
$45.09 - $50.03 $192,940 - $214,078
-4,279 Reduced 17.93%
19,582 $979,000
Q4 2022

Feb 13, 2023

SELL
$39.56 - $47.22 $12,065 - $14,402
-305 Reduced 1.26%
23,861 $1.1 Million
Q3 2022

Nov 23, 2022

SELL
$36.71 - $109.66 $5,947 - $17,764
-162 Reduced 0.67%
24,166 $936,000
Q2 2022

Aug 03, 2022

SELL
$35.24 - $47.1 $31,821 - $42,531
-903 Reduced 3.58%
24,328 $907,000
Q1 2022

Jul 21, 2022

BUY
$40.9 - $45.1 $1.03 Million - $1.14 Million
25,231 New
25,231 $1.12 Million

Others Institutions Holding BSX

About BOSTON SCIENTIFIC CORP


  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Gould Capital, LLC Portfolio

Follow Gould Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gould Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gould Capital, LLC with notifications on news.